KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBT Margin: 2018-2025

Historic EBT Margin for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -27.15%.

  • Twist Bioscience's EBT Margin rose 1387.00% to -27.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -20.43%, marking a year-over-year increase of 4608.00%. This contributed to the annual value of -20.43% for FY2025, which is 4608.00% up from last year.
  • Per Twist Bioscience's latest filing, its EBT Margin stood at -27.15% for Q3 2025, which was down 226.72% from 21.43% recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's EBT Margin ranged from a high of 21.43% in Q2 2025 and a low of -133.20% during Q4 2021.
  • In the last 3 years, Twist Bioscience's EBT Margin had a median value of -59.95% in 2024 and averaged -54.99%.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by 3,360bps in 2021, then surged by 12,623bps in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's EBT Margin stood at -133.20% in 2021, then surged by 5,624bps to -76.96% in 2022, then soared by 1,698bps to -59.98% in 2023, then skyrocketed by 2,448bps to -35.50% in 2024, then skyrocketed by 1,387bps to -27.15% in 2025.
  • Its EBT Margin stands at -27.15% for Q3 2025, versus 21.43% for Q2 2025 and -42.19% for Q1 2025.